Publications by authors named "Ruben Oliveira-Sousa"
Article Synopsis
- Accurate diagnosis and risk assessment for prostate cancer (PCa) patients is crucial for ensuring the best treatment outcomes, especially for those with low- and intermediate-risk disease who may opt for active surveillance (AS).
- A study developed risk calculators based on cancer biomarkers, such as Ki67 and KLF8 levels, to better distinguish which patients might benefit from more proactive interventions.
- The resulting prognostic model, known as ProstARK, showed promising accuracy in predicting biochemical recurrence-free survival, but further validation in larger studies is needed to confirm its effectiveness for patient selection in AS protocols.
